Combination Therapy Effective In Improving Lung Cancer Survival

by Medindia Content Team on  April 29, 2004 at 9:58 AM General Health News
RSS Email Print This Page Comment
Font : A-A+

Combination Therapy Effective In Improving Lung Cancer Survival
Researchers from Japan say that the combination of chemotherapy with a new medication could improve survival among lung cancer patients.

In the study of close to 1,000 patients, the overall survival rate was significantly higher in patients who received chemotherapy and the oral drug uracil-tegafur. Results of the study show 65 patients who received the combined therapy died within five years compared to 89 patients who received no therapy.

Researchers also found a recurrence or second primary cancer in 23 percent of the treatment group and 26 percent of the non-treatment group. Of the 482 patients who received treatment, only 10 patients experienced toxicity problems. Treatment was stopped if patients experienced a grade 3 level of toxicity.

However specialists say that though the study provides compelling evidence that uracil-tegafur can improve survival for stage I lung cancer patients , the drug has still not been approved in the United States, Thus limiting its use only to trials.

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Lung Biopsy Lung Cancer Malignant Mesothelioma Cancer and Homeopathy Reiki and Pranic Healing Cancer Facts Asbestosis Cancer Pneumoconiosis Smoking among Women 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive